Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04395924 Completed - COVID-19 Clinical Trials

Maternal-foetal Transmission of SARS-Cov-2

TMF-COVID-19
Start date: May 5, 2020
Phase:
Study type: Observational

One case of maternal-fetal transmission of SARS Cov-2 was published (1). Ig M and Ig G were found at two hours after birth of a new born from a mother COVID-19. Another study on few newborns COVID-19 reported that the SARS-Cov-2 was not transmitted in utero but only after birth. Although there are few data on COVID-19 during pregnancy, according to our national data collections, it appears to be responsible for miscarriages and fetal deaths. There are also intrauterine growth restrictions and an increase of the rate of cesarean sections for maternal indications. Therefore, it is essential to know if there is a maternal viremia which infects the fetus because the consequences in terms of management would be completely different. In fact, the potential intrauterine infection will lead to antenatal monitoring of these patients with an antenatal diagnosis and may be a treatment. Therefore, it seems essential to explore the mode of transmission to the newborn since many newborns have COVID-19 infection The investigators will propose to all pregnant women SARS- Cov-2 positive to perform PCR SARS-Cov-2 tests and /or serology's (IgM and Ig G) on the amniotic fluid, the blood cord and the placenta.

NCT ID: NCT04395911 Completed - COVID Clinical Trials

Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections

Start date: September 10, 2020
Phase: N/A
Study type: Interventional

Selective Cytopheretic Device (SCD) treatments will improve survival in patients testing positive for COVID-19 infection diagnosed with Acute Kidney Injury (AKI) or ARDS.

NCT ID: NCT04395859 Completed - Clinical trials for Diabetic Macular Edema

Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents

COVIDIV
Start date: May 27, 2020
Phase:
Study type: Observational

In patients treated for exudative age-related macular degeneration (AMD), diabetes, retinal venous occlusion (OVR), or other conditions causing macular edema, treatments with anti-angiogenic intravitreal injections (IVT) are widely used both for their anti-angiogenic action. Patients often have injections for many years, sometimes monthly or every 2 months. The discontinuation of treatment with repeated injections of anti-angiogenic agents, linked to the COVID-19 coronavirus pandemic will potentially impact the visual acuity, the ophthalmological state and the quality of life of the patients concerned, therefore it is relevant to analyze the consequences the breakdown of usual care in this population.

NCT ID: NCT04395833 Completed - Clinical trials for Identify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 Pandemic

National Survey on the Lockdown of Children With Disabilities

ECHO
Start date: April 7, 2020
Phase:
Study type: Observational

During the COVID-19 pandemic, lockdown measures were established in France affecting the life course of children with disabilities. This study aimed at identifying the experiences, main difficulties and needs of these children and their parents during the lockdown period.

NCT ID: NCT04395781 Completed - COVID Clinical Trials

Pediatric Acute and Critical Care COVID-19 Registry of Asia

PACCOVRA
Start date: May 18, 2020
Phase:
Study type: Observational [Patient Registry]

In December 2019, an outbreak of pneumonia of unknown aetiology was first reported in the city of Wuhan, Hubei Province, People's Republic of China. Since then, a novel coronavirus, 2019 novel Coronavirus (2019-nCoV) has emerged as the most likely causative agent. To date, it has evolved into a pandemic involving over a million cases and thousands of deaths have been identified, including a high burden in countries like Italy, Spain, United Kingdom and the United States. This study aims to investigate the clinical epidemiology of 2019-novel coronavirus (2019-nCoV) pandemic in Asia.

NCT ID: NCT04395755 Completed - COVID-19 Clinical Trials

Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed

Start date: April 1, 2020
Phase:
Study type: Observational

Infertility is a severely distressing experience for many couples. Depression and anxiety are psychological disorders associated with infertility, and they may worsen during infertility treatments. This study times to understand the changes in the psychological status of infertile patients who had in vitro fertilization (IVF) treatment interrupted or postponed because of the COVID-19 pandemic.

NCT ID: NCT04395664 Completed - COVID-19 Clinical Trials

Arrhythmias in Patients With COVID-19

ACOVID
Start date: April 16, 2020
Phase:
Study type: Observational

The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.

NCT ID: NCT04395482 Completed - covid19 Clinical Trials

Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury

TAC-COVID19
Start date: May 7, 2020
Phase:
Study type: Observational

This is a multicenter observational retrospective cohort study that aims to study the morphological characteristics of the lung parenchyma of SARS-CoV2 positive patients identifiable in patterns through artificial intelligence techniques and their impact on patient outcome.

NCT ID: NCT04395391 Completed - COVID-19 Clinical Trials

Home Usability Study of the SARS-CoV-2 (COVID-19) Test

Start date: May 18, 2020
Phase:
Study type: Observational

The primary objective is to determine the usability of the SARS-CoV-2 Specimen Collection Materials for at-home collection and mailing of sample to the testing laboratory.

NCT ID: NCT04395300 Completed - COVID-19 Clinical Trials

Sleep Quality in Healthcare Personnel During COVID-19

Start date: March 30, 2020
Phase:
Study type: Observational

Coronavirus disease 2019 (COVID-19), represents a medical and psychological challenge to healthcare workers to the limits that it affects their quality of sleep and their general health.